AstraZeneca buys US biotech firm CinCor
Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.
Jan 9, 2023
0
2
Anglo-Swedish pharmaceuticals giant AstraZeneca on Monday agreed to buy US biotech company CinCor for $1.8 billion, expanding further into the field of heart and kidney drugs.
Jan 9, 2023
0
2
From a scientist's laptop to the syringe used to inject the UK's first COVID vaccine dose, an exhibition that opened Wednesday in London recounts the quest to produce a coronavirus jab through objects.
Nov 30, 2022
0
12
Nasal vaccines could still be a powerful future weapon in the fight against COVID-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say.
Oct 18, 2022
0
51
Canada is going to throw out about 13.6 million doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad.
Jul 6, 2022
0
23
A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barré syndrome (GBS), has been identified by University College London ...
May 30, 2022
0
419
India began offering booster doses of COVID-19 vaccine to all adults on Sunday but limited free shots at government centers to front-line workers and people over age 60.
Apr 10, 2022
0
2
A third 'booster' dose of COVID-19 vaccine successfully raises antibody levels that neutralize the Omicron variant, according to laboratory findings from the Francis Crick Institute and the National Institute for ...
Jan 20, 2022
0
108
The University of Oxford's vaccine manufacturing research team has today published a pre-print paper demonstrating the feasibility of a step change in the speed and volume of production of adenovirus-vectored vaccines against ...
Dec 22, 2021
0
2
The protection offered by the Oxford-AstraZeneca COVID-19 vaccine declines after three months of receiving two doses, a study says.
Dec 20, 2021
0
213
Last week, AstraZeneca's chief executive officer said the company's COVID vaccine may provide longer-lasting protection than mRNA vaccines like Pfizer's, especially in older people.
Nov 29, 2021
0
1